Acurx Pharmaceuticals LLC

Stock Chart, Company Information, and Scan Results

$2.38(as of Apr 17, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Acurx Pharmaceuticals LLC Company Information, Fundamentals, and Technical Indicators

Stock Price$2.38
Ticker SymbolACXP
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees4
CountyUSA
Market Cap$6.8M

Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus (MRSA), vancomycin resistant enterococcus (VRE), and drug-resistant streptococcus pneumoniae (DRSP), as well as B. anthracis. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.

Acurx Pharmaceuticals LLC In Our Stock Scanner

As of Apr 20, 2026
example chart graphic
Scan Name: Double BottomScan Type: Chart Pattern Scans
As of ---
As of ---
example chart graphic
Scan Name: Low PB RatioScan Type: Stock Fundamentals
As of ---
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.